No Long-Term Effect of Behavioral Treatment on Psychotropic Drug Use for Agitation in Alzheimer's Disease Patients

Abstract

To determine if teaching caregivers behavior management techniques (BMTs) reduces long-term psychotropic use in Alzheimer's disease (AD) patients, we examined 12-month follow-up data from a 4-month randomized study com paring placebo, BMTs, trazodone, and haloperidol for the treatment of agitated behaviors in persons with AD. After 4 months, treatment was allowed with any agent. Between 42.8% and 51% of AD patients received additional psy chotropics between 4 and 12 months. The relative risk of being prescribed any psychotropic drug after the 4-month trial was at or about 1.0 for subjects in each drug arm or placebo arm versus BMTs. We concluded that teaching caregivers BMTs did not diminish long-term prescription of psychotropic drugs. (J Geriatr Psychiatry Neurol 2002; 15:95-98).

Get full access to this article

View all access options for this article.

References

Hussian RA Behavioral geriatrics. Progr Behav Modif 1984 ; 1:159-183.

Teri L. , Logsdon R. Assessment and management of behavioral disturbances in Alzheimer's disease . Compr Ther 1990; 16:36-42.

Weiner MF , Gray KF Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease . Am J Alzheimer Dis 1994; 9:6-12.

Weinrich S. , Egbert C. , Eleazer BP , et al. Agitation: measurement, management, and intervention research . Arch Psychiatr Nurs 1995; 9:251-260.

Swanwick Grj. Nonpharmacological treatment of behavioral symptoms. In: Lawlor BA , ed. Behavioral complications in Alzheimer's disease. Washington, DC: American Psychiatric Press, 1995:183-208.

Thal LJ

Development of the Alzheimer's Disease Cooperative Study

Int J Geriatr Psychopharmacol 1997; 1:6-9.

Teri L. , Logsdon RG , Peskind E. , et al, and members of the Alzheimer's Disease Cooperative Study. Treatment of agitation in Alzheimer's disease patients: a randomized placebo controlled clinical trial. Neurology 2000; 55:1271-1278.

Schneider LS , Olin JT , Doody RS , et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Dis Assoc Disord 1997; 11(Suppl 2):22-32.

Cohen-Mansfield J. Agitated behaviors in the elderly II: preliminary results in the cognitively deteriorated. J Am Gertatr Soc 1986;34:722-727.

10.

Tariot PN , Mack JL , Patterson MB , et al, and the Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavior Rating Scale of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152:1349-1357.

11.

Logsdon R. , Teri L. , Weiner MF , et al, and Members of the Alzheimer's Disease Cooperative Study. Assessment of agitation in Alzheimer's disease: the Agitated Behavior in Dementia Scale . JAm Geriatr Soc 1999; 47:1354-1358.

12.

Teri L. , Truax P. , Logsdon R. , et al. Assessment of behavioral problems in dementia: the Revised Memory and Behavior Problem Checklist. Psychol Aging 1992; 4:622-631.

13.

Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.

14.

Reisberg R. , Borestein J. , Salob SP , et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 49(Suppl 5):9-15.

15.

Haupt M. , Kurz A. , Janner M. A two-year follow-up of behavioral and psychological symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11:147-152.

16.

Teri L. , Logsdon RG , Uomoto J. , et al. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol Psychol Sci Soc Sci 1997; 52:P159-P166.